参考文献/References:
[1] Zhang L,Long J,Jiang W,et al.Trends in chronic kidney disease in China[J].N Engl J Med,2016,375(9): 905-906.DOI:10.1056/NEJMc1602469.
[2] van Swelm RPL,Wetzels JFM,Swinkels DW.The multifaceted role of iron in renal health and disease[J].Nat Rev Nephrol,2020,16(2):77-98.DOI:10.1038/s41581-019-0197-5.
[3] Zhao L,Zou Y,Zhang J,et al.Serum transferrin predicts end-stage renal disease in type 2 diabetes mellitus patients[J].Int J Med Sci,2020,17(14):2113-2124.DOI:10.7150/ijms.46259.
[4] Chaudhary K,Chilakala A,Ananth S,et al.Renal iron accelerates the progression of diabetic nephropathy in the HFE gene knockout mouse model of iron overload[J].Am J Physiol Renal Physiol,2019,317(2):F512-F517.DOI:10.1152/ajprenal.00184.2019.
[5] Wang F,Lv H,Zhao B,et al.Iron and leukemia:new insights for future treatments[J].J Exp Clin Cancer Res,2019,38(1):406.DOI:10.1186/s13046-019-1397-3.
[6] Coffey R,Knutson MD.The plasma membrane metal-ion transporter ZIP14 contributes to nontransferrin-bound iron uptake by human β-cells[J].Am J Physiol Cell Physiol,2017,312(2):C169-C175.DOI:10.1152/ajpcell.00116.2016.
[7] Jahng JWS,Alsaadi RM,Palanivel R,et al.Iron overload inhibits late stage autophagic flux leading to insulin resistance[J].EMBO Rep,2019,20(10):e47911.DOI:10.15252/embr.201947911.
[8] Tatsch E,De Carvalho JAM,Bollick YS,et al.Low frataxin mRNA expression is associated with inflammation and oxidative stress in patients with type 2 diabetes[J].Diabetes Metab Res Rev,2020,36(1):e3208.DOI:10.1002/dmrr.3208.
[9] Fujita Y,Doi Y,Hamano T,et al.Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia:a prospective cohort study[J].Sci Rep,2019,9(1):14871.DOI:10.1038/s41598-019-51207-8.
[10] Liu J,Li Q,Yang Y,et al.Iron metabolism and type 2 diabetes mellitus:a meta-analysis and systematic review[J].J Diabetes Investig,2020,11(4):946-955.DOI:10.1111/jdi.13216.
[11] Zhang D,Ye S,Pan T.The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes[J].PeerJ,2019,7:e7079.DOI:10.7717/peerj.7079.
[12] Yasumura S,Naito Y,Okuno K,et al.Effects of heterozygous TfR1(Transferrin Receptor 1)deletion in pathogenesis of renal fibrosis in mice[J].Hypertension,2020,75(2):413-421.DOI:10.1161/HYPERTENSIONAHA.119.13670.
[13] Ueda N,Takasawa K.Impact of inflammation on ferritin,hepcidin and the management of iron deficiency snemia in chronic kidney disease[J].Nutrients,2018,10(9):1173.DOI:10.3390/nu10091173.
[14] Hayder ZS,Kareem ZS.Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin[J].Int Urol Nephrol,2020,52(4):749-756.DOI:10.1007/s11255-020-02434-w.
[15] 刘岳鹏.血清铁调素-25水平与2型糖尿病肾病中肾功能不良进展的相关性研究[J].国际检验医学杂志,2020,41(5):532-535.DOI:10.3969/j.issn.1673-4130.2020.05.005.
[16] Belo L,Rocha S,Valente MJ,et al.Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients[J].Ren Fail,2019,41(1):662-672.DOI:10.1080/0886022X.2019.1635893.
[17] Wojtaszek E,Glogowski T,Malyszko J.Iron and chronic kidney disease:still a challenge[J].Front Med(Lausanne),2020,7:565135.DOI:10.3389/fmed.2020.565135.
[18] Tang S,Xiao X.Ferroptosis and kidney diseases[J].Int Urol Nephrol,2020,52(3):497-503.DOI:10.1007/s11255-019-02335-7.
[19] Li S,Zheng L,Zhang J,et al.Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy[J].Free Radic Biol Med,2021,162:435-449.DOI:10.1016/j.freeradbiomed.2020.10.323.
[20] Kim S,Kang SW,Joo J,et al.Characterization of ferroptosis in kidney tubular cell death under diabetic conditions[J].Cell Death Dis,2021,12(2):160.DOI:10.1038/s41419-021-03452-x.
[21] Zhang Q,Hu Y,Hu JE,et al.Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis[J].Life Sci,2021,278:119529.DOI:10.1016/j.lfs.2021.119529.
[22] Lee H,Zandkarimi F,Zhang Y,et al.Energy-stress-mediated AMPK activation inhibits ferroptosis[J].Nat Cell Biol,2020,22(2):225-234.DOI:10.1038/s41556-020-0461-8.
[23] Szrejder M,Rachubik P,Rogacka D,et al.Metformin reduces TRPC6 expression through AMPK activation and modulates cytoskeleton dynamics in podocytes under diabetic conditions[J].Biochim Biophys Acta Mol Basis Dis,2020,1866(3):165610.DOI:10.1016/j.bbadis.2019.165610.
[24] Wu Y,Zhao Y,Yang HZ,et al.HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose[J].Biosci Rep,2021,41(2):BSR20202924.DOI:10.1042/BSR20202924.
[25] Wang Y,Bi R,Quan F,et al.Ferroptosis involves in renal tubular cell death in diabetic nephropathy[J].Eur J Pharmacol,2020,888:173574.DOI:10.1016/j.ejphar.2020.173574.
[26] 中国医师协会肾脏内科医师分会肾性贫血指南工作组; 陈香美,孙雪峰.中国肾性贫血诊治临床实践指南[J].中华医学杂志,2021,101(20):1463-1502.DOI:10.3760/cma.j.cn112137-20210201-00309.
相似文献/References:
[1]张盈莹,卓永,欧佩,等.尿NGAL及KIM-1水平对藏区糖尿病
肾脏病的临床诊断价值研究[J].国际内分泌代谢杂志,2020,40(05):294.[doi:10.3760/cma.j.cn121383-20200502-05027]
Zhang Yingying,Zhuo Yong,Ou Pei,et al.The clinical diagnostic value of urine NGAL and KIM-1 in diabetic kidney disease in Tibet area of China[J].International Journal of Endocrinology and Metabolism,2020,40(05):294.[doi:10.3760/cma.j.cn121383-20200502-05027]
[2]蒋俊兰 刘尚全.血尿酸/肌酐比值与早期糖尿病肾脏病进展的关系[J].国际内分泌代谢杂志,2022,42(01):17.[doi:10.3760/cma.j.cn121383-20201024-10029]
Jiang Junlan,Liu Shangquan..Relationship between serum uric acid to creatinine ratio and progression of early diabetic kidney disease[J].International Journal of Endocrinology and Metabolism,2022,42(05):17.[doi:10.3760/cma.j.cn121383-20201024-10029]
[3]文婧怡,郭立新.急性高糖诱发肾小管相关白蛋白尿的发病机制[J].国际内分泌代谢杂志,2022,42(03):195.[doi:10.3760/cma.j.cn121383-20210302-03003]
Wen Jingyi,Guo Lixin..Pathogenesis of acute hyperglycemia-induced renal tubular-associated albuminuria[J].International Journal of Endocrinology and Metabolism,2022,42(05):195.[doi:10.3760/cma.j.cn121383-20210302-03003]
[4]赵耕 牛文彦.中性粒细胞明胶酶相关脂质运载蛋白在代谢相关肾损伤中的应用价值分析[J].国际内分泌代谢杂志,2022,42(04):272.[doi:10.3760/cma.j.cn121383-20210928-09084]
Zhao Geng,Niu Wenyan..Application value of neutrophil gelatinase related lipid carrier protein in metabolism related renal injury[J].International Journal of Endocrinology and Metabolism,2022,42(05):272.[doi:10.3760/cma.j.cn121383-20210928-09084]
[5]乐颖,蒋科威,薛萌,等.microRNA-31对高糖条件下人足细胞上皮-间充质转分化的影响[J].国际内分泌代谢杂志,2022,42(05):354.[doi:10.3760/cma.j.cn121383-20210426-04077]
Le Ying,Jiang Kewei,Xue Meng,et al.Effects of microRNA-31 on high-glucose induced epithelial-mesenchymal transition of podocytes[J].International Journal of Endocrinology and Metabolism,2022,42(05):354.[doi:10.3760/cma.j.cn121383-20210426-04077]